COXANTO
- Product NDC
- 70512-814
- 11-digit product format
- 705120814
- Labeler code
- 70512
- Product ID
- 70512-814_419ad65e-5326-0755-e063-6394a90a7b2f
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- oxaprozin
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- SOLA Pharmaceuticals, LLC
- Application
- NDA217927
- Marketing category
- NDA
- Marketing start
- 2025-11-03
- Substance
- OXAPROZIN
- Active strength
- 300 mg/1
- Pharmacologic classes
- Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- COXANTO
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| OXAPROZIN | 300 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | MHJ80W9LRB |
| Rxcui | 2668162, 2668168 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 70512-814-60 | COXANTO | 60 in 1 BOTTLE | CAPSULE | 60 | | 2 |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 70512-814-60 | 70512081460 | 60 CAPSULE in 1 BOTTLE (70512-814-60) | 60 capsule | 2025-11-03 | No | No | Historical |